INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Hospital General de Granollers
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital General de Granollers (29)
2024
-
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Clinical and Translational Oncology
2023
-
A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
Hematology (United Kingdom), Vol. 28, Núm. 1
-
Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands
International Journal of Epidemiology, Vol. 52, Núm. 4, pp. E241-E252
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study
Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127
-
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study
Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693
2022
-
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*
British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
-
Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
Journal of Clinical Medicine, Vol. 11, Núm. 11
2021
-
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Parestomal hernia repair. Prospective observational study based on the Spanish Registry of Incisional Hernia (EVEREG)
Cirugia Espanola, Vol. 99, Núm. 7, pp. 527-534
-
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice
Blood Cancer Journal
2020
-
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
British Journal of Dermatology, Vol. 183, Núm. 1, pp. 71-77
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066
-
Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study
Dermatologic Therapy, Vol. 33, Núm. 6
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4
-
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group
Annals of Hematology, Vol. 99, Núm. 4, pp. 799-808
2019
-
Multicentric study on total pancreatectomies
Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384
-
Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study
Clinical Breast Cancer, Vol. 19, Núm. 2, pp. 105-112
2016
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302